Müller Hannes, Gabrielli Valeria, Agoglitta Oriana, Holl Ralph
Institut für Pharmazeutische und Medizinische Chemie der Westfälischen Wilhelms-Universität Münster, Corrensstr. 48, D-48149 Münster, Germany.
Institut für Pharmazeutische und Medizinische Chemie der Westfälischen Wilhelms-Universität Münster, Corrensstr. 48, D-48149 Münster, Germany; NRW Graduate School of Chemistry, University of Münster, Germany.
Eur J Med Chem. 2016 Mar 3;110:340-75. doi: 10.1016/j.ejmech.2016.01.032. Epub 2016 Jan 20.
Inhibitors of the bacterial deacetylase LpxC have emerged as a promising new class of Gram-negative selective antibacterials. In order to find novel LpxC inhibitors, in chiral-pool syntheses starting from d-mannose, C-furanosides with altered configuration in positions 2 and/or 5 of the tetrahydrofuran ring were prepared in stereochemically pure form. Additionally, the substitution pattern in positions 3 and 4 of the tetrahydrofuran ring as well as the structure of the lipophilic side chain in position 2 were varied. Finally, all stereoisomers of the respective open chain diols were obtained via glycol cleavages of properly protected C-glycosides. The biological evaluation of the synthesized hydroxamic acids revealed that in case of the C-glycosides, 2,5-trans-configuration generally leads to superior inhibitory and antibacterial activities. The relief of the conformational strain leading to the respective open chain derivatives generally caused an increase in the inhibitory and antibacterial activities of the benzyloxyacetohydroxamic acids. With Ki-values of 0.35 μm and 0.23 μm, the (S,S)-configured open-chain derivatives 8b and 8c were found to be the most potent LpxC inhibitors of these series of compounds.
细菌脱乙酰酶LpxC抑制剂已成为一类有前景的新型革兰氏阴性菌选择性抗菌药物。为了寻找新型LpxC抑制剂,在以d-甘露糖为起始原料的手性池合成中,制备了四氢呋喃环2位和/或5位构型改变的C-呋喃糖苷,且其具有立体化学纯的形式。此外,还改变了四氢呋喃环3位和4位的取代模式以及2位亲脂性侧链的结构。最后,通过适当保护的C-糖苷的二醇裂解得到相应开链二醇的所有立体异构体。对合成的异羟肟酸进行生物学评价发现,对于C-糖苷而言,2,5-反式构型通常具有更优异的抑制活性和抗菌活性。导致相应开链衍生物的构象应变的缓解通常会使苄氧基乙酰异羟肟酸的抑制活性和抗菌活性增加。(S,S)-构型的开链衍生物8b和8c的Ki值分别为0.35μm和0.23μm,是这些系列化合物中最有效的LpxC抑制剂。